(Q52404383)

1 May 2018

title

The effect of differing radiotherapeutic schedules on the response of glottic carcinoma of the larynx. (English)

1 reference

1 May 2018

0 references

3

P Boyle

1 reference

1 May 2018

A G Robertson

1

1 reference

1 May 2018

C Robertson

series ordinal

2

1 reference

1 May 2018

R P Symonds

series ordinal

4

1 reference

1 May 2018

T E Wheldon

series ordinal

5

1 reference

1 May 2018

publication date

1 January 1993

1 reference

1 May 2018

European Journal of Cancer

published in

1 reference

1 May 2018

volume

29A

1 reference

1 May 2018

page(s)

501-510

1 reference

1 May 2018

issue

4

1 reference

1 May 2018

Cancer of the larynx. I. Natural history in relation to treatment

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

The American Society of Therapeutic Radiologists Presidential Address: October 1981. Potential for improving survival rates for the cancer patient by increasing the efficacy of treatment of the primary lesion

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Dose, time and fractionation: A clinical hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Cumulative radiation effect part I: Fractionated treatment regimes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Reasons for irradiation failure in squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

The steepness of the dose response curve both for tumor cure and normal tissue injury

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

RADIUM TREATMENT OF INTRINSIC CARCINOMA OF THE LARYNX.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Radiotherapy of early glottic cancer—I

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Management of advanced glottic cancer a 10 year review of the Toronto experience

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

The influence of field size, treatment modality, commissure involvement and histology in the treatment of early vocal cord cancer with irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Radiation treatment of laryngeal carcinoma with special reference to CRE values

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Radiotherapy of early glottic cancer—II

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

The influence of the number of fractions and of overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx: tumor dose-response and repopulation.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Dose fractionation and regeneration in radiotherapy for cancer of the oral cavity and oropharynx. Part 2. Normal tissue responses: acute and late effects

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Continuous hyperfractionated accelerated radiotherapy in locally advanced carcinoma of the head and neck region

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

The linear-quadratic formula and progress in fractionated radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Time-dose factors in radiotherapy: a review of the human data.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Twice-a-day radiation therapy for supraglottic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Twice-a-day radiation therapy for cancer of the head and neck

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

The predictive value of cell kinetic measurements in a European trial of accelerated fractionation in advanced head and neck tumors: an interim report

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Cell proliferation and differentiation in squamous cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Alpha/beta value and the importance of size of dose per fraction for late complications in the supraglottic larynx

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

Hypofractionation reduces the therapeutic ratio in early glottic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2805%2980139-X

7 January 2021

10.1016/S0959-8049(05)80139-X

Identifiers

DOI

1 reference

1 May 2018

PubMed ID

8435200

1 reference

1 May 2018